Healing Hearts & Empowering Care
Through Trust,
Innovation, &
Partnership.
Vasomedical Timeline
Since 1995 provided innovative, reliable, and accessible diagnostic and therapeutic solutions. Our mission is to help physicians detect, understand, and manage heart and vascular diseases earlier and more effectively — so patients can live longer, healthier, and fuller lives.
1995 – EECP® Foundation
-
Commercialization of EECP® therapy systems
-
Core business focused on non-invasive cardiovascular therapy
-
U.S. and international sales & servicing
2010 – Portfolio Expansion
-
Introduction of BIOX™ products
-
Entry into ambulatory ECG & BP monitoring
-
Establishment of China-based manufacturing & R&D
2011 – Biox™ Full Ownership
-
Completion of 100% ownership of Biox™ Instruments
-
Consolidation of device IP and production control
-
Strengthened global regulatory footprint
2021–Present – SaaS Transformation
-
Expansion of ARCS® Cloud platform
-
Subscription-based ECG/BP analysis & reporting
-
Portfolio centered on:
-
Biox™ ambulatory monitors
-
ARCS® Cloud platform
-
Bridging technology and humanity so every heartbeat has a better chance
Patients
Proven Relief — EECP® and advanced ARCS® monitoring solutions deliver non-invasive care that restores confidence and quality of life.
Physicians
Clarity You Can Trust — ARCS Cloud turns ECG data into actionable insights, reducing workload while improving patient outcomes.
Providers
Scale with Confidence — Secure, automated, and compliant solutions built to support high-volume cardiac monitoring and program growth.